Restraint High Price The GLP-1 drugs are expensive, which in turn, limits their use
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
Macronutrients, micronutrients and fluids People with obesity may have risk factors for malnutrition and micronutrient deficiencies which are exacerbated when they embark on weight reduction diets and obesity medications [48,63,64]
Eliquis was initially approved in the European Union in 2011 and received approval in the United States the following year
It comes down to pharmacokinetics
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.2025 Dietary Guidelines Advisory Committee